- Home
- BRLT vs SONN Comparison
BRLT vs SONN Comparison
Compare BRLT & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- SONN
- Stock Information
- Founded
- BRLT 2005
- SONN N/A
- Country
- BRLT United States
- SONN United States
- Employees
- BRLT N/A
- SONN N/A
- Industry
- BRLT Consumer Specialties
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- SONN Health Care
- Exchange
- BRLT Nasdaq
- SONN Nasdaq
- Market Cap
- BRLT 19.8M
- SONN 21.4M
- IPO Year
- BRLT 2021
- SONN N/A
- Fundamental
- Price
- BRLT $2.36
- SONN $5.54
- Analyst Decision
- BRLT Hold
- SONN Strong Buy
- Analyst Count
- BRLT 2
- SONN 1
- Target Price
- BRLT $1.80
- SONN $20.00
- AVG Volume (30 Days)
- BRLT 306.9K
- SONN 960.3K
- Earning Date
- BRLT 11-06-2025
- SONN 08-13-2025
- Dividend Yield
- BRLT 10.50%
- SONN N/A
- EPS Growth
- BRLT N/A
- SONN N/A
- EPS
- BRLT N/A
- SONN N/A
- Revenue
- BRLT $422,218,000.00
- SONN $1,000,000.00
- Revenue This Year
- BRLT $5.55
- SONN $5,376.22
- Revenue Next Year
- BRLT $3.88
- SONN N/A
- P/E Ratio
- BRLT N/A
- SONN N/A
- Revenue Growth
- BRLT N/A
- SONN 1689.52
- 52 Week Low
- BRLT $1.25
- SONN $1.08
- 52 Week High
- BRLT $3.10
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- BRLT 49.28
- SONN 68.98
- Support Level
- BRLT $2.75
- SONN $2.71
- Resistance Level
- BRLT $2.70
- SONN $6.65
- Average True Range (ATR)
- BRLT 0.28
- SONN 0.67
- MACD
- BRLT -0.07
- SONN 0.28
- Stochastic Oscillator
- BRLT 26.00
- SONN 71.83
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.